μ receptor (oprm_human)
FAMILY
Class A (Rhodopsin) Peptide receptors Opioid receptors μ receptor
GENE
OPRM1 (MOR1)
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Mu-type opioid receptor, M-OR-1, MOR-1, Mu opiate receptor, Mu opioid receptor, MOP, hMOP
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
D
|
S
|
S
|
A
|
A
|
P
|
T
|
N
|
A
|
10 |
S
|
N
|
C
|
T
|
D
|
A
|
L
|
A
|
Y
|
S
|
20 |
S
|
C
|
S
|
P
|
A
|
P
|
S
|
P
|
G
|
S
|
30 |
W
|
V
|
N
|
L
|
S
|
H
|
L
|
D
|
G
|
N
|
40 |
L
|
S
|
D
|
P
|
C
|
G
|
P
|
N
|
R
|
T
|
50 |
D
|
L
|
G
|
G
|
R
|
D
|
S
|
L
|
C
|
P
|
60 |
TM1 | |||||||||
P
|
T
|
G
|
S
|
P
|
S
|
M
|
I
|
T
|
A
|
70 |
I
|
T
|
I
|
M
|
A
|
L
|
Y
|
S
|
I
|
V
|
80 |
C
|
V
|
V
|
G
|
L
|
F
|
G
|
N
|
F
|
L
|
90 |
V
|
M
|
Y
|
V
|
I
|
V
|
R
|
Y
|
T
|
K
|
100 |
ICL1 | TM2 | ||||||||
M
|
K
|
T
|
A
|
T
|
N
|
I
|
Y
|
I
|
F
|
110 |
N
|
L
|
A
|
L
|
A
|
D
|
A
|
L
|
A
|
T
|
120 |
S
|
T
|
L
|
P
|
F
|
Q
|
S
|
V
|
N
|
Y
|
130 |
ECL1 | TM3 | ||||||||
L
|
M
|
G
|
T
|
W
|
P
|
F
|
G
|
T
|
I
|
140 |
L
|
C
|
K
|
I
|
V
|
I
|
S
|
I
|
D
|
Y
|
150 |
Y
|
N
|
M
|
F
|
T
|
S
|
I
|
F
|
T
|
L
|
160 |
C
|
T
|
M
|
S
|
V
|
D
|
R
|
Y
|
I
|
A
|
170 |
ICL2 | |||||||||
V
|
C
|
H
|
P
|
V
|
K
|
A
|
L
|
D
|
F
|
180 |
TM4 | |||||||||
R
|
T
|
P
|
R
|
N
|
A
|
K
|
I
|
I
|
N
|
190 |
V
|
C
|
N
|
W
|
I
|
L
|
S
|
S
|
A
|
I
|
200 |
G
|
L
|
P
|
V
|
M
|
F
|
M
|
A
|
T
|
T
|
210 |
ECL2 | |||||||||
K
|
Y
|
R
|
Q
|
G
|
S
|
I
|
D
|
C
|
T
|
220 |
TM5 | |||||||||
L
|
T
|
F
|
S
|
H
|
P
|
T
|
W
|
Y
|
W
|
230 |
E
|
N
|
L
|
L
|
K
|
I
|
C
|
V
|
F
|
I
|
240 |
F
|
A
|
F
|
I
|
M
|
P
|
V
|
L
|
I
|
I
|
250 |
T
|
V
|
C
|
Y
|
G
|
L
|
M
|
I
|
L
|
R
|
260 |
ICL3 | |||||||||
L
|
K
|
S
|
V
|
R
|
M
|
L
|
S
|
G
|
S
|
270 |
TM6 | |||||||||
K
|
E
|
K
|
D
|
R
|
N
|
L
|
R
|
R
|
I
|
280 |
T
|
R
|
M
|
V
|
L
|
V
|
V
|
V
|
A
|
V
|
290 |
F
|
I
|
V
|
C
|
W
|
T
|
P
|
I
|
H
|
I
|
300 |
Y
|
V
|
I
|
I
|
K
|
A
|
L
|
V
|
T
|
I
|
310 |
ECL3 | TM7 | ||||||||
P
|
E
|
T
|
T
|
F
|
Q
|
T
|
V
|
S
|
W
|
320 |
H
|
F
|
C
|
I
|
A
|
L
|
G
|
Y
|
T
|
N
|
330 |
S
|
C
|
L
|
N
|
P
|
V
|
L
|
Y
|
A
|
F
|
340 |
H8 | |||||||||
L
|
D
|
E
|
N
|
F
|
K
|
R
|
C
|
F
|
R
|
350 |
C-term | |||||||||
E
|
F
|
C
|
I
|
P
|
T
|
S
|
S
|
N
|
I
|
360 |
E
|
Q
|
Q
|
N
|
S
|
T
|
R
|
I
|
R
|
Q
|
370 |
N
|
T
|
R
|
D
|
H
|
P
|
S
|
T
|
A
|
N
|
380 |
T
|
V
|
D
|
R
|
T
|
N
|
H
|
Q
|
L
|
E
|
390 |
N
|
L
|
E
|
A
|
E
|
T
|
A
|
P
|
L
|
P
|
400 |
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
endomorphin-2, dynorphin A-(1-13), endomorphin-1, dynorphin A, dynorphin A-(1-8), [Met]enkephalin, dynorphin B, [Leu]enkephalin, β-endorphin